Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study

To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. We previously developed partial wave spectroscopic mi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PloS one Ročník 10; číslo 2; s. e0115999
Hlavní autoři: Roy, Hemant K., Brendler, Charles B., Subramanian, Hariharan, Zhang, Di, Maneval, Charles, Chandler, John, Bowen, Leah, Kaul, Karen L., Helfand, Brian T., Wang, Chi-Hsiung, Quinn, Margo, Petkewicz, Jacqueline, Paterakos, Michael, Backman, Vadim
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Public Library of Science 23.02.2015
Public Library of Science (PLoS)
Témata:
ISSN:1932-6203, 1932-6203
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200 nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells. There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
AbstractList Purpose To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. Materials and Methods We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells. Results There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. Conclusions We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
Purpose To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. Materials and Methods We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20–200nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells. Results There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. Conclusions We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells. There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated.PURPOSETo determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated.We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200 nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells.MATERIALS AND METHODSWe previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200 nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells.There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach.RESULTSThere was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach.We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.CONCLUSIONSWe demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
PurposeTo determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated.Materials and methodsWe previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200 nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells.ResultsThere was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach.ConclusionsWe demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200 nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a ~3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa ~150 histologically normal epithelial cells. There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1±0.065 versus 1.30±0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.
Audience Academic
Author Helfand, Brian T.
Chandler, John
Wang, Chi-Hsiung
Roy, Hemant K.
Kaul, Karen L.
Subramanian, Hariharan
Maneval, Charles
Paterakos, Michael
Quinn, Margo
Bowen, Leah
Backman, Vadim
Brendler, Charles B.
Zhang, Di
Petkewicz, Jacqueline
AuthorAffiliation 4 Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, United States of America
3 Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America
1 Department of Medicine, Boston University Medical Center, Boston, Massachusetts, United States of America
2 Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America
University of Kentucky College of Medicine, UNITED STATES
AuthorAffiliation_xml – name: 4 Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, United States of America
– name: 1 Department of Medicine, Boston University Medical Center, Boston, Massachusetts, United States of America
– name: 2 Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America
– name: University of Kentucky College of Medicine, UNITED STATES
– name: 3 Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America
Author_xml – sequence: 1
  givenname: Hemant K.
  surname: Roy
  fullname: Roy, Hemant K.
– sequence: 2
  givenname: Charles B.
  surname: Brendler
  fullname: Brendler, Charles B.
– sequence: 3
  givenname: Hariharan
  surname: Subramanian
  fullname: Subramanian, Hariharan
– sequence: 4
  givenname: Di
  surname: Zhang
  fullname: Zhang, Di
– sequence: 5
  givenname: Charles
  surname: Maneval
  fullname: Maneval, Charles
– sequence: 6
  givenname: John
  surname: Chandler
  fullname: Chandler, John
– sequence: 7
  givenname: Leah
  surname: Bowen
  fullname: Bowen, Leah
– sequence: 8
  givenname: Karen L.
  surname: Kaul
  fullname: Kaul, Karen L.
– sequence: 9
  givenname: Brian T.
  surname: Helfand
  fullname: Helfand, Brian T.
– sequence: 10
  givenname: Chi-Hsiung
  surname: Wang
  fullname: Wang, Chi-Hsiung
– sequence: 11
  givenname: Margo
  surname: Quinn
  fullname: Quinn, Margo
– sequence: 12
  givenname: Jacqueline
  surname: Petkewicz
  fullname: Petkewicz, Jacqueline
– sequence: 13
  givenname: Michael
  surname: Paterakos
  fullname: Paterakos, Michael
– sequence: 14
  givenname: Vadim
  surname: Backman
  fullname: Backman, Vadim
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25706755$$D View this record in MEDLINE/PubMed
BookMark eNqNk21r1EAQx4NU7IN-A9FAQfTFnfuQTbJ9IRyn1UK1YtW3y9xmkm7Z2z2zm2K_vRvvWnqliCQh4T-_-U92mNnPdpx3mGXPKZlSXtG3l37oHdjpKslTQqmQUj7K9qjkbFIywnfufO9m-yFcEiJ4XZZPsl0mKlJWQuxlwxdwXl9Hb31nNNj82KBt8jn02jjfocNgQv4eI-povMujzz-baDqImJ9dYd8Y6JwfGd_mX3sf4hiZg9PYH-WzUUqBdM99klYxP49Dc_00e9yCDfhs8z7Ifhx_-D7_NDk9-3gyn51OdCXqOGGgBaMVaWWBJacgJdJFQReSAnCUtGFcV6wuabNogBCNNQctCSQFWFtyfpC9XPuurA9q07GgaClqkh4xEidrovFwqVa9WUJ_rTwY9Vfwfaegj0ZbVKKRLUNeCNKKQgqxaGTBuCBFU6dSskxe7zbVhsUSG40u9mC3TLcjzlyozl-pgvOaCpoMXm8Mev9rwBDV0gSN1oJDP6z_u2CMMJHQw3vow6fbUB2kAxjX-lRXj6ZqloxEUdWUJGr6AJWuBpdGp_FqTdK3Et5sJSQm4u_YwRCCOjn_9v_s2c9t9tUd9gLBxovg7TBOXtgGX9zt9G2Lb-Y6AcUa0GkkQ4_tLUKJGtfnpl1qXB-1WZ-UdnQvTZs00Kl86oix_07-AwY2H44
CitedBy_id crossref_primary_10_1002_jbio_201500298
crossref_primary_10_1038_s41391_020_0206_6
crossref_primary_10_1002_jbio_202500114
crossref_primary_10_1038_s41467_019_09717_6
crossref_primary_10_1117_1_JBO_24_1_016502
crossref_primary_10_2217_fon_15_182
crossref_primary_10_1002_cam4_1357
crossref_primary_10_1016_j_mehy_2016_10_026
crossref_primary_10_1038_528S124a
crossref_primary_10_1038_s41551_017_0153_2
crossref_primary_10_1371_journal_pone_0194320
crossref_primary_10_1002_jcb_27156
crossref_primary_10_1038_s41598_022_13332_9
crossref_primary_10_1155_2016_6090912
crossref_primary_10_1038_srep41061
Cites_doi 10.1016/j.urology.2013.09.075
10.1002/pros.20983
10.1016/S0016-5085(13)60624-1
10.1016/j.juro.2013.06.021
10.1016/j.eururo.2008.06.043
10.1158/1940-6207.CAPR-08-0174
10.1038/modpathol.2014.81
10.1055/s-0033-1344617
10.1158/0008-5472.CAN-08-3895
10.1186/1471-2407-14-129
10.1073/pnas.0804723105
10.1177/1535370214539091
10.1001/jama.2011.879
10.1172/JCI72589
10.1155/2012/302894
10.1097/CCO.0000000000000065
10.1158/0008-5472.CAN-03-3264
10.1016/j.ajpath.2012.03.043
10.1002/ijc.28122
10.1158/0008-5472.CAN-11-3807
10.1111/bju.12318
10.1016/j.eururo.2014.03.026
10.1001/jama.2013.108415
10.1016/j.ajpath.2013.02.040
10.1126/scitranslmed.3006408
10.1056/NEJMoa1208962
10.1056/NEJMcp0706784
10.3322/caac.21208
10.1016/j.juro.2007.05.039
10.1158/0008-5472.CAN-10-1686
10.1053/j.gastro.2010.11.023
10.1007/s004280000290
10.1002/cncr.22534
10.1093/jnci/djt151
10.2217/fon.10.176
10.7326/0003-4819-157-2-201207170-00459
10.7326/0003-4819-156-8-201204170-00010
10.1056/NEJMoa0804525
10.7150/jca.5838
10.1016/j.bpj.2010.05.023
ContentType Journal Article
Copyright COPYRIGHT 2015 Public Library of Science
2015 Roy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2015 Roy et al 2015 Roy et al
Copyright_xml – notice: COPYRIGHT 2015 Public Library of Science
– notice: 2015 Roy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2015 Roy et al 2015 Roy et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0115999
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest SciTech Premium Collection Technology Collection Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest One Academic
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


Agricultural Science Database

MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Engineering
DocumentTitleAlternate Nanocytology Predicts Outcomes in Early Prostate Cancer
EISSN 1932-6203
ExternalDocumentID 1658065853
oai_doaj_org_article_5d9f2e3450f54955bd9423504d863396
PMC4338151
3602769871
A422547810
25706755
10_1371_journal_pone_0115999
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
Illinois
GeographicLocations_xml – name: United States--US
– name: Illinois
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: U01CA111257
– fundername: NCI NIH HHS
  grantid: R01 CA156186
– fundername: NCI NIH HHS
  grantid: R42 CA168055
– fundername: NCI NIH HHS
  grantid: R01CA156186
– fundername: NCI NIH HHS
  grantid: R01CA165309
– fundername: NCI NIH HHS
  grantid: R01CA128641
– fundername: NCI NIH HHS
  grantid: R01 CA155284
– fundername: NCI NIH HHS
  grantid: R01 CA128641
– fundername: NCI NIH HHS
  grantid: R01 CA165309
– fundername: NCI NIH HHS
  grantid: R42CA168055
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACCTH
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFFHD
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAIFH
BAWUL
BBNVY
BBTPI
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
ALIPV
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
ESTFP
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
PUEGO
5PM
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c758t-2ac52170f94e631a99e1b41b91aa3e91d23c72861dbda00ce83ac90a861a2f633
IEDL.DBID FPL
ISICitedReferencesCount 24
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000350662100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1932-6203
IngestDate Sun Feb 05 03:13:57 EST 2023
Tue Oct 14 19:06:51 EDT 2025
Tue Nov 04 01:34:41 EST 2025
Sun Sep 28 02:11:14 EDT 2025
Tue Oct 07 07:58:22 EDT 2025
Sat Nov 29 13:05:13 EST 2025
Sat Nov 29 10:10:12 EST 2025
Wed Nov 26 10:28:03 EST 2025
Wed Nov 26 10:13:55 EST 2025
Thu May 22 20:50:50 EDT 2025
Wed Feb 19 02:30:06 EST 2025
Sat Nov 29 01:32:21 EST 2025
Tue Nov 18 21:15:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-2ac52170f94e631a99e1b41b91aa3e91d23c72861dbda00ce83ac90a861a2f633
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
Competing Interests: Drs. Roy, Subramanian and Backman are co-founders of Nanocytomics LLC and managed by the conflict of interest committees of Boston University and Northwestern University. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: HR CB HS KK BH VB. Performed the experiments: HS DZ CM JC LB KK BH MQ JP MP. Analyzed the data: HS DZ CM JC LB CW. Contributed reagents/materials/analysis tools: HS DZ CM JC LB CW KK. Wrote the paper: HR CB HS VB.
OpenAccessLink http://dx.doi.org/10.1371/journal.pone.0115999
PMID 25706755
PQID 1658065853
PQPubID 1436336
ParticipantIDs plos_journals_1658065853
doaj_primary_oai_doaj_org_article_5d9f2e3450f54955bd9423504d863396
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4338151
proquest_miscellaneous_1658422025
proquest_journals_1658065853
gale_infotracmisc_A422547810
gale_infotracacademiconefile_A422547810
gale_incontextgauss_ISR_A422547810
gale_incontextgauss_IOV_A422547810
gale_healthsolutions_A422547810
pubmed_primary_25706755
crossref_primary_10_1371_journal_pone_0115999
crossref_citationtrail_10_1371_journal_pone_0115999
PublicationCentury 2000
PublicationDate 2015-02-23
PublicationDateYYYYMMDD 2015-02-23
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02-23
  day: 23
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2015
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References DA Sartori (ref33) 2014; 26
D Damania (ref21) 2013; 133
SA Kenfield (ref26); 305
L Nonn (ref13) 2009; 69
JL Campos-Fernandes (ref36) 2009; 55
LC Chen (ref39) 2004; 64
PC Walsh (ref2) 2007; 357
RA Fillmore (ref41) 2014; 239
LJ Esserman (ref1) 2013; 310
VJ Konda (ref19) 2013; 45
Y Hoshida (ref37) 2008; 359
S Irshad (ref32) 2013; 5
GP Dotto (ref10) 2014; 124
R Siegel (ref28) 2014; 64
F Kosari (ref11) 2012; 181
V Backman (ref7) 2011; 140
HB Carter (ref4) 2013; 112
D Damania (ref17) 2012; 72
DR Aberle (ref30) 2013; 369
JH Luo (ref12) 2013; 182
Y Zhang (ref15) 2014; 14
DM Latini (ref6) 2007; 178
VA Moyer (ref29) 2012; 157
ref23
KA Trujillo (ref34) 2012; 2012
H Subramanian (ref16) 2008; 105
AR Zlotta (ref3) 2013; 105
K RJ Steiling (ref8) 2008; 1
D Damania (ref40) 2010; 99
PA Ganz (ref5) 2012; 156
V Backman (ref22) 2013; 4
Z Gong (ref25) 2007; 109
D Sundi (ref24) 2014; 191
HK Roy (ref18) 2010; 70
ref9
H Subramanian (ref20) 2009; 69
AK Tiwari (ref38) 2013; 144
HK Roy (ref31) 2011; 7
AJ Vickers (ref27) 2014; 83
RL Parr (ref14) 2013; 15
R Montironi (ref35) 2000; 437
References_xml – volume: 83
  start-page: 592
  year: 2014
  ident: ref27
  article-title: A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer
  publication-title: Urology
  doi: 10.1016/j.urology.2013.09.075
– volume: 69
  start-page: 1470
  year: 2009
  ident: ref13
  article-title: Evidence for field cancerization of the prostate
  publication-title: Prostate
  doi: 10.1002/pros.20983
– volume: 144
  start-page: 1
  year: 2013
  ident: ref38
  article-title: Partial Wave Spectroscopic Microscopy: A Novel Tool to Assess Perturbation in teh Cellular Transcriptional Activity During Colon Carcinogenesis
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(13)60624-1
– volume: 191
  start-page: 60
  year: 2014
  ident: ref24
  article-title: Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men
  publication-title: J Urol
  doi: 10.1016/j.juro.2013.06.021
– volume: 55
  start-page: 600
  year: 2009
  ident: ref36
  article-title: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2008.06.043
– volume: 1
  start-page: 396
  year: 2008
  ident: ref8
  article-title: the field of tissue injury in the lung and airway
  publication-title: Cancer Prev Res
  doi: 10.1158/1940-6207.CAPR-08-0174
– ident: ref9
  doi: 10.1038/modpathol.2014.81
– volume: 45
  start-page: 983
  year: 2013
  ident: ref19
  article-title: Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening
  publication-title: Endoscopy
  doi: 10.1055/s-0033-1344617
– volume: 69
  start-page: 5357
  year: 2009
  ident: ref20
  article-title: Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-3895
– volume: 14
  start-page: 129
  year: 2014
  ident: ref15
  article-title: Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-129
– volume: 105
  start-page: 20118
  year: 2008
  ident: ref16
  article-title: Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0804723105
– volume: 239
  start-page: 793
  year: 2014
  ident: ref41
  article-title: New concepts concerning prostate cancer screening
  publication-title: Exp Biol Med (Maywood)
  doi: 10.1177/1535370214539091
– volume: 305
  start-page: 2548
  ident: ref26
  article-title: Smoking and prostate cancer survival and recurrence
  publication-title: Jama
  doi: 10.1001/jama.2011.879
– volume: 124
  start-page: 1446
  year: 2014
  ident: ref10
  article-title: Multifocal epithelial tumors and field cancerization: stroma as a primary determinant
  publication-title: J Clin Invest
  doi: 10.1172/JCI72589
– volume: 2012
  start-page: 302894
  year: 2012
  ident: ref34
  article-title: Markers of field cancerization: proposed clinical applications in prostate biopsies
  publication-title: Prostate Cancer
  doi: 10.1155/2012/302894
– volume: 26
  start-page: 259
  year: 2014
  ident: ref33
  article-title: Biomarkers in prostate cancer: what's new?
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0000000000000065
– volume: 64
  start-page: 3694
  year: 2004
  ident: ref39
  article-title: Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-3264
– volume: 181
  start-page: 34
  year: 2012
  ident: ref11
  article-title: Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2012.03.043
– volume: 133
  start-page: 1143
  year: 2013
  ident: ref21
  article-title: Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28122
– volume: 72
  start-page: 2720
  year: 2012
  ident: ref17
  article-title: Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-3807
– volume: 112
  start-page: 543
  year: 2013
  ident: ref4
  article-title: American Urological Association (AUA) guideline on prostate cancer detection: process and rationale
  publication-title: BJU Int
  doi: 10.1111/bju.12318
– ident: ref23
  doi: 10.1016/j.eururo.2014.03.026
– volume: 310
  start-page: 797
  year: 2013
  ident: ref1
  article-title: Overdiagnosis and overtreatment in cancer: an opportunity for improvement
  publication-title: JAMA
  doi: 10.1001/jama.2013.108415
– volume: 182
  start-page: 2028
  year: 2013
  ident: ref12
  article-title: Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2013.02.040
– volume: 5
  start-page: 202ra122
  year: 2013
  ident: ref32
  article-title: A molecular signature predictive of indolent prostate cancer
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3006408
– volume: 369
  start-page: 920
  year: 2013
  ident: ref30
  article-title: Results of the two incidence screenings in the National Lung Screening Trial
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1208962
– volume: 357
  start-page: 2696
  year: 2007
  ident: ref2
  article-title: Clinical practice. Localized prostate cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp0706784
– volume: 64
  start-page: 9
  year: 2014
  ident: ref28
  article-title: Cancer statistics, 2014
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21208
– volume: 178
  start-page: 826
  year: 2007
  ident: ref6
  article-title: The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance
  publication-title: J Urol
  doi: 10.1016/j.juro.2007.05.039
– volume: 15
  start-page: 213
  year: 2013
  ident: ref14
  article-title: Mitochondria, prostate cancer, and biopsy sampling error
  publication-title: Discov Med
– volume: 70
  start-page: 7748
  year: 2010
  ident: ref18
  article-title: Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-1686
– volume: 140
  start-page: 35
  year: 2011
  ident: ref7
  article-title: Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.11.023
– volume: 437
  start-page: 625
  year: 2000
  ident: ref35
  article-title: Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections
  publication-title: Virchows Arch
  doi: 10.1007/s004280000290
– volume: 109
  start-page: 1192
  year: 2007
  ident: ref25
  article-title: Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men
  publication-title: Cancer
  doi: 10.1002/cncr.22534
– volume: 105
  start-page: 1050
  year: 2013
  ident: ref3
  article-title: Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djt151
– volume: 7
  start-page: 1
  year: 2011
  ident: ref31
  article-title: Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification
  publication-title: Future Oncol
  doi: 10.2217/fon.10.176
– volume: 157
  start-page: 120
  year: 2012
  ident: ref29
  article-title: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-157-2-201207170-00459
– volume: 156
  start-page: 591
  year: 2012
  ident: ref5
  article-title: National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-156-8-201204170-00010
– volume: 359
  start-page: 1995
  year: 2008
  ident: ref37
  article-title: Gene expression in fixed tissues and outcome in hepatocellular carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0804525
– volume: 4
  start-page: 251
  year: 2013
  ident: ref22
  article-title: Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification
  publication-title: J Cancer
  doi: 10.7150/jca.5838
– volume: 99
  start-page: 989
  year: 2010
  ident: ref40
  article-title: Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture
  publication-title: Biophys J
  doi: 10.1016/j.bpj.2010.05.023
SSID ssj0053866
Score 2.2860866
Snippet To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason...
Purpose To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage...
PurposeTo determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage...
Purpose To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0115999
SubjectTerms Aged
Biomedical engineering
Cancer
Cancer research
Carcinogenesis
Carcinogenesis - pathology
Carcinogens
Case-Control Studies
Cellular structure
Demographics
Disease control
Early Detection of Cancer
Engineering
Epithelial cells
Esophagus
Gene expression
Heterogeneity
Humans
Interrogation
Male
Mathematical morphology
Medical diagnosis
Medical Overuse
Medical prognosis
Medical screening
Microscopy
Middle Aged
Mucosa
Neoplasm Grading
Prognosis
Prostate - pathology
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Questioning
Smoking
Spatial heterogeneity
Surgery
Surveillance
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQigMXRHk1bQGDkIBD2iR2nJhbQVQgoYJ4VL1Fju2UlUqy2mQr8e-ZsZ3QoErlgLQnz2QfM-PxZ-3MN4Q8TzXPG85lXBjFY66FiJXUTcwSWXNhVNI4noKTj8XxcXl6Kj9fGvWFNWGeHtgb7iA3ssks43nSwFUmz2sjAQHkCTelYEw6sm1APeNlyudg2MVChEY5VqQHwS_7q661-wiCpON6_XMQOb7-KSsvVuddfxXk_Lty8tJRdHSH3A4Ykh76775Fbtj2LtkKu7SnLwOV9Kt7ZAPJs9O_hjHDUVewRjUOEGq7M8xzy54aO7iCrJYOHf25dKwblmJtp_GFeKDTNXSFDSIo0Rgp69dU4RII4KV99yN1bLX3yfejd9_evo_DoIVYw3VhiDOl4RQvwC_cCpYqKW1a87SWqVLMytRkTBdZKVJTg_cSbUumtEwUrKisATc8IIsWTLtNqGTayppJa8FdWmQS4KgsjcAJ7LnNZETYaPVKBxZyHIZxXrm_1gq4jXgjVuirKvgqIvH01MqzcFyj_wYdOukih7ZbgMiqQmRV10VWRJ5gOFS-IXXKBNUhhxyIHbpJRJ45DeTRaLFQ50xt-r768OnkH5S-fpkpvQhKTQfm0Co0R8BvQn6umebeTBOygZ6JtzF4R6v0VQoQE2FmzuDJMaCvFj-dxPimWHzX2m7jdeADAB1H5KGP_8myOAQR7pwgKWY7Y2b6uaRd_nA05pwBWszTnf_hq11yC5Cs5xpge2QxrDf2EbmpL4Zlv37scsNv3CRoug
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELeg8AAPwMbHAgMMQgIesiWx49S8oFKoQIKt4mPaW-Q4Tqk0JaVJkfbfc-c42YImQELqk--Sxr4Pn5O73xHyLNQ8LjiXfpIr7nMthK-kLnwWyIyLXAWFxSk4-pgcHIyPj-XcvXCrXVpl5xOto84rje_I90PYKnG7jNnr1Q8fu0bh11XXQuMyuYIoCcym7s07Twy2LIQrl2NJuO-ks7eqSrOHoZC0iK9n25FF7e9982h1UtUXBZ6_50-e25BmN_93KrfIDReK0kmrO1vkkim3yfVzAIXbZMuZfk1fOHzql7fJBjxypU-bzm3SGWbB0Sl2JSqrBTrPZU3fmsZmeZW0qeinpYXyMPQQLCdvs_uApyroHKtOkDJF9Vu_ohMcAgL8pm1JJcVcx9M75Nvs3dfpe991b_A1nEEaP1IaQoMEhM2NYKGS0oQZDzMZKsWMDPOI6SQaizDPQCUCbcZMaRkoGFFRIRi7S0YlSGqHUMm0kRmTxhQxqFMkIcaV41xgW_fYRNIjrBNiqh20OXbYOEnt97oEjjjtkqYo-tSJ3iN-f9Wqhfb4C_8b1I-eF4G57UC1XqTOztM4l0VkGI8DeFQZx1kuIWCNA56PYUpSeOQxalfaVrn27iWdcHCsWPYbeOSp5UBwjhKzfxZqU9fph8Ojf2D68nnA9NwxFRUsh1au4gLmhKBfA87dASe4GD0g76AtdKtSp2caDFd2On4x-UlPxptiRl9pqk3LA38AIbdH7rXm1K8sdlaEgyxQkoGhDZZ-SCmX3y02OmcQgsbh_T8_1gNyDQLfFpqA7ZJRs96Yh-Sq_tks6_Uj60R-AZH6e60
  priority: 102
  providerName: ProQuest
Title Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study
URI https://www.ncbi.nlm.nih.gov/pubmed/25706755
https://www.proquest.com/docview/1658065853
https://www.proquest.com/docview/1658422025
https://pubmed.ncbi.nlm.nih.gov/PMC4338151
https://doaj.org/article/5d9f2e3450f54955bd9423504d863396
http://dx.doi.org/10.1371/journal.pone.0115999
Volume 10
WOSCitedRecordID wos000350662100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: P5Z
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Agricultural Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M0K
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/agriculturejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7P
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Engineering Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7S
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Environmental Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PATMY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/environmentalscience
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7X7
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Materials Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KB.
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/materialsscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: BENPR
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25.
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7RV
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8C1
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PIMPY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVATS
  databaseName: Public Library of Science (PLoS) Journals Open Access
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: FPL
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.plos.org/publications/
  providerName: Public Library of Science
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdYxwM8ABsfK4wSEBLwkJLEiRPz1pZVTFu7aIOq8BI5jjMqTUnVpEj777lz0rBMmwCpugffuXXOvvO5ufuZkLe2dL3UdbnpJ8I1XcmYKbhMTWrx2GWJsFKNUzA79qfTYD7n4Z-D4rU3-NS3P9Y67S_zTPUxgIGQZotsO5QxTOEah8cbzwu2y1hdHndbz9b2o1H6G1_cWV7kxU2B5vV8ySsb0Pjh_w79EXlQh5rGoFobO-SOynbJ_SsAhLtkpzbtwnhf409_eEzW4HFzeVlu3KIxxiw3Y4S3DmX5OTrHRWF8VqXO4sqMMjcmCw3VoYwTsIykyt4DmTw1QqwqQc4Il9fqkzHAJmDAZ1SVTBqYy3j5hHwbH3wdfTHr2xlMCWeM0nSEhK3fh8l0FaO24FzZsWvH3BaCKm4nDpW-EzA7iWHKLakCKiS3BLQIJ2WUPiWdDBSzRwxOpeIx5UqlHiwXh0MMy4OE4bXtnnJ4l9DNpEWyhi7HGzQuIv0-zocjTKXSCDUd1ZruErPptaygO_4iP8T10Mgi8LZugCmNajuOvISnjqKuZ8FQuefFCYeA1LPcJIBH4qxLXuFqiqoq1sZ9RAMXHCeW9Vpd8kZLIPhGhtk952JdFNHhyewfhM5OW0LvaqE0B3VIUVdUwDMhqFdLcr8lCS5Etth7uPY3WikiG-JSjE09Cj039nAz-3XDxi_FjL1M5etKBn4AQuoueVaZT6NZvDkRDqrA8VuG1VJ9m5Mtfmrsc5dCiOnZz28f8QtyD4LaCnaA7pNOuVqrl-Su_FUuilWPbPmnM6RzX9MAaDCye2R7eDANT3v6P5meditAj4Z9oBPrCKkfanoGNPR-QI_wcBJ-_w0Rx3aW
linkProvider Public Library of Science
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF5VAQl6AFqgDRS6IBBwcGt713YWCaGQEjVqmlalRL2Z9XodIlV2iB1Q_hS_kRm_WqMKuPSAlNPOOFlPZr6ZtedByAtLcSfiXBheKLnBlesaUqjIYKYIuBtKM8r7FIyH3mjUOTsTxyvkZ1ULg2mVFSbmQB0mCp-R71rgKtFdOuz97JuBU6Pw7Wo1QqNQiwO9_AFHtvTdYA_-35e23f942ts3yqkChoLYODNsqcBlebAJrl1mSSG0FXArEJaUTAsrtJny7I5rhQFs1VS6w6QSpoQVaUcuPgAFyL8BOG5hCpl3Mq6QH7DDdcvyPOZZu6U27MySWO9g6CXyDrMX7i-fElD7gtbsPEmvCnR_z9e85AD7d_830d0jd8pQm3YL21gjKzpeJ6uXGjCuk7US2lL6uuy__eY-WYDHSdQyq9wC7WOWH-3h1KU4maBzmKZ0T2d5FltMs4QeTvNWJZoeATKERfYi8CQRPcaqGqT00Lzmb2kXl4AAn15RMkoxl3P5gHy-FmE8JK0YNGOTUMGUFgETWkcOmIstIIYXndDFsfWOtkWbsEppfFW2bscJIud-_j7SgyNcIVIfVc0vVa1NjPqqWdG65C_8H1Afa15sPJ4vJPOJX-KY74QisjXjjglbFY4ThAICcsfkYQduSbhtso3a7BdVvDV8-l0OjgPLms02eZ5zYPORGLObJnKRpv7gaPwPTJ9OGkyvSqYoAXEoWVaUwD1hU7MG51aDEyBUNcibaHuVVFL_wmLgysqmriY_q8n4pZixGOtkUfDAD8CRok02CvOtJYuTI-GgDhSvYdgN0Tcp8fRr3vudMwixHevRn7e1TW7tnx4O_eFgdPCY3IYgv2jDwLZIK5sv9BNyU33Ppun8aQ5glHy5brP_BTVU2Ck
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF5VASE4AC2PBgpdEAg4uLG9azuLhFBIiIha0ohH1ZtZr9chUmWHOAHlr_HrmLHXbo0q4NIDUk4742Q9mdfaM98Q8sRR3Es4F1YQS25x5fuWFCqxmC0i7sfSTgqcgqODYDzuHh-LyQb5WfXCYFll5RMLRx1nCp-RdxwIlRguPdZJTFnEZDB8Pf9m4QQpfNNajdMoVWRfr3_A8S1_NRrAf_3UdYdvP_XfWWbCgKUgT15arlQQvgLYENc-c6QQ2om4EwlHSqaFE7tMBW7Xd-IItm0r3WVSCVvCinQTHx-Ggvu_FDDQYuxS79flJeBHfN-06rHA6RjN2Jtnqd7DNEwUaLOnobCYGFDHhdb8JMvPS3p_r908EwyHN_5nMd4k100KTnulzWySDZ1ukWtngBm3yKZxeTl9bnC5X9wiK4hEmVovq3BBh1j9R_s4jSnNphg0Zjkd6GVR3ZbSZUbfzwoIE00PwWPEZVUj8GQJnWC3DVL6aHaLl7SHS0CAT79sJaVY47m-TT5fiDDukFYKWrJNqGBKi4gJrRMPzMgVkNuLbuzjOHtPu6JNWKVAoTKQ7jhZ5CQs3lMGcLQrRRqi2oVG7drEqq-al5Amf-F_g7pZ8yIgebGQLaah8W-hF4vE1Yx7NmxVeF4UC0jUPZvHXbgl4bfJLmp2WHb31m417HEIKNjubLfJ44IDQUlS1MupXOV5ODo8-gemjx8aTM8MU5KBOJQ0nSZwTwh21uDcaXCCa1UN8jbaYSWVPDy1Hriysq_zyY9qMn4pVjKmOluVPPADcNRok7ulKdeSxYmScIAHStAw8obom5R09rXAhOcMUm_Puffnbe2SK2Dt4cFovH-fXIXcv0RnYDuktVys9ANyWX1fzvLFw8KXUfLloq3-F82U4IQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanocytological+field+carcinogenesis+detection+to+mitigate+overdiagnosis+of+prostate+cancer%3A+a+proof+of+concept+study&rft.jtitle=PloS+one&rft.au=Roy%2C+Hemant+K&rft.au=Brendler%2C+Charles+B&rft.au=Subramanian%2C+Hariharan&rft.au=Zhang%2C+Di&rft.date=2015-02-23&rft.eissn=1932-6203&rft.volume=10&rft.issue=2&rft.spage=e0115999&rft_id=info:doi/10.1371%2Fjournal.pone.0115999&rft_id=info%3Apmid%2F25706755&rft.externalDocID=25706755
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon